Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of New vs Current Pulmicort Turbuhaler in Pediatric Asthma
NCT00642161Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2002
- Primary completion
- Sep 2004
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of budesonide in asthma (3 arms), sponsored by AstraZeneca. Primary endpoint: Forced Expiratory Volume in 1 second at 12 weeks. Started Nov 2002; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00642161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642161.